• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Partial vision recovery after iatrogenic retinal artery occlusion.

by HBOT News | Apr 5, 2014 | Central Retinal Artery Occlusion (CRAO)

Abstract: To describe the first case of partial vision recovery in a 32-year-old woman with iatrogenic retinal artery occlusion (RAO) following glabella calcium hydroxylapatite (CaHA) injection, and to explore appropriate diagnostic and therapeutic measures according...

Systemic wound care: a meta-review of cochrane systematic reviews.

by HBOT News | Apr 5, 2014 | Burns

Abstract: Wound care is a classic example of a surgical realm with a great variation in care. The diversity in wounds and wound treatments, the limited amount of convincing evidence, and the diverging opinions among doctors and nurses involved in wound care contribute...

Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.

by HBOT News | Apr 2, 2014 | Amytrophic Lateral Sclerosis (ALS)

Abstract: Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disorder of motor neurons causing progressive muscle weakness, paralysis, and eventual death from respiratory failure. There is currently no cure or...

Late hyperbaric oxygen treatment of cilioretinal artery occlusion with nonischemic central retinal vein occlusion secondary to high altitude.

by HBOT News | Mar 29, 2014 | Central Retinal Artery Occlusion (CRAO)

Abstract: To report a case of cilioretinal artery occlusion (CRAO) with central retinal vein occlusion (CRVO) after a journey to high altitude region and the use of late period hyperbaric oxygen (HBO) therapy successfully. A previously healthy 48-year-old lowlander...

Hyperbaric oxygen therapy fails to reduce hydrocephalus formation following subarachnoid hemorrhage in rats.

by HBOT News | Mar 24, 2014 | Stroke

Abstract: Approximately 40% of hemorrhagic stroke survivors develop hydrocephalus. Hyperbaric oxygen (HBO) has been shown to be anti-inflammation following experimental stroke; however, its effect upon post-hemorrhagic hydrocephalus formation is not known. The...
« Older Entries
Next Entries »

Recent Posts

  • Treat the Concussion: How HBOT Is Changing the Playbook for Concussions — An Interview with Dr. Daphne Denham
  • Understanding Hyperbaric Chambers: Types, Risks, and Safety Tips for Patients
  • Overcoming the Placebo Challenge: New Trial Confirms HBOT Benefits for TBI and PTSD
  • Concussion Recovery: New Study Supports HBOT for Student Athletes
  • Can Oxygen Make You Younger? What Bryan Johnson’s $2M HBOT Experiment Really Tells Us

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.